Code of practice needed for samples donated by trial participants - 01/03/22
Doi : 10.1016/S1470-2045(22)00059-6
Robert Coleman a, Arlene Chan b, Carlos Barrios c, David Cameron d, Luis Costa e, Mitch Dowsett f, David Harrison g, Anthony Howell h, i, Denis Lacombe j, Mairead MacKenzie k, Miguel Martin l, Stuart McIntosh m, Adrienne Morgan k, Martine Piccart n, Tanja Spanic o
a Department of Oncology and Metabolism, University of Sheffield Sheffield, S10 2RX, UK
b School of Medicine, Curtin University, Perth, Australia
c Centro de Pesquisa em Oncologia, Hospital São Lucas, PUCRS, Porto Alegre, Brazil
d Cancer Research UK Edinburgh Centre, University of Edinburgh Western General Hospital, Edinburgh, UK
e Hospital de Santa Maria, Lisbon, Portugal
f Institute of Cancer Research and Honorary Clinical Scientist, Royal Marsden Hospital, London, UK
g School of Medicine, University of St Andrews, St Andrews, UK
h Division of Cancer Sciences, University of Manchester, Manchester, UK
i Christie Hospital NHS Trust: The Christie NHS Foundation Trust, Manchester, UK
j European Organisation for Research and Treatment of Cancer Data Centre, Brussels, Belgium
k Independent Cancer Patients’ Voice, London, UK
l Hospital General Universitario Gregorio Marañón, Madrid, Spain
m School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, Northern Ireland
n Jules Bordet Institute, Brussels, Belgium
o Europa Donna, The European Breast Cancer Coalition, Milan, Italy
Le texte complet de cet article est disponible en PDF.
© 2022
Elsevier Ltd. Tous droits réservés.
Vol 23 - N° 3
P. e89-e90 - mars 2022 Retour au numéro
Article précédent
- Retraction and republication—Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
- Code of practice needed for samples donated by trial participants – Sponsor’s reply
- Doug Warner, Anthony Glennane, Byeong Yoon, Hossam Saad
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?